Shanghai Yizhong Pharmaceutical Past Performance
Past criteria checks 3/6
Shanghai Yizhong Pharmaceutical has been growing earnings at an average annual rate of 90.8%, while the Pharmaceuticals industry saw earnings growing at 8.8% annually. Revenues have been growing at an average rate of 665.3% per year. Shanghai Yizhong Pharmaceutical's return on equity is 12.1%, and it has net margins of 56.8%.
Earnings growth rate
EPS growth rate
|Pharmaceuticals Industry Growth||8.8%|
|Revenue growth rate||665.3%|
|Return on equity||12.1%|
|Last Earnings Update||31 Mar 2023|
Recent past performance updates
Earnings and Revenue History
Quality Earnings: 688091 has a high level of non-cash earnings.
Growing Profit Margin: 688091's current net profit margins (56.8%) are lower than last year (83.9%).
Past Earnings Growth Analysis
Earnings Trend: 688091 has become profitable over the past 5 years, growing earnings by 90.8% per year.
Accelerating Growth: 688091's earnings growth over the past year (418.2%) exceeds its 5-year average (90.8% per year).
Earnings vs Industry: 688091 earnings growth over the past year (418.2%) exceeded the Pharmaceuticals industry 15.3%.
Return on Equity
High ROE: 688091's Return on Equity (12.1%) is considered low.